Pharma Journalist -

Target PharmaSolutions asserts that Novartis has entered into strategic alliance for TARGET-NASH. TARGET-NASH is a longitudinal observational study that assesses adult and pediatric…
Read More...

Adimab partners with Boehringer Ingelheim to discover and optimize antibodies against targets selected by BI who exclusively possesses the right to develop and commercialize therapeutic…
Read More...

It is noteworthy that U.S FDA has accepted an investigational New Drug Application for MORAb-202, an antibody-drug conjugate (ADC), to treat solid tumors that express folate receptor…
Read More...

Aeon global health asserts that Armando Moncada, MD, FCAP appointed as its Chief medical officer of its Anatomy Pathology business line ushering in on board 20 years of expertise and…
Read More...

Syndax Pharmaceuticals that is developing entinostat and SNDX-6352 in multiple cancer indications declared collaboration with a member of Roche Group, Genentech to evaluate  the…
Read More...

Kalorama states that IVD industry has embarked on  an approach to advance IVD innovations in Sepsis. Sepsis is characterized by tedious detection in its early stages as  fever,…
Read More...

Pharmaceutical company ALK introduction of its sublingual allergy immunotherapy (SLIT) tablet ODACTRA set to be rolled out for US Patients in the age group of 18- 65 years afflicted…
Read More...

After the Bone, Reproductive and Urologic Drugs Advisory Committee ("BRUDAC") of the U.S. Food and Drug Administration ("FDA") voted six in favor and thirteen against the benefit/risk…
Read More...

Braeburn Pharmaceutical asserts completion of its $110- million mezzanine financing among a few others like Avista Capital Partners, RA Capital Management, New Leaf Venture Partners,…
Read More...

Biodegradable balloon spacers, BioProtect announces the launch of Clinical Trial followed by the FDA approval for Investigational Device Exemption in November , 2017 that seeks to…
Read More...